The Lipodystrophy Syndrome in HIV-Infected Children under Antiretroviral Therapy: A First Report from the Central Africa

Table 3

Laboratory features in the study population according to serologic status and treatment.

	HIV-Infected + ARVs n()	Negative HIV n()	Naive HIV-infected n()	p
Cholesterol (mg/dl)				0.05
Hyper (> 200)	6 (7.5)	1 (1.2)	0 (0.0)
HDL-Cholesterol (mg/dl)				0.25
Hyper (>150)	2 (2.5)	1 (1.2)	1 (1.5)
Triglycerides (mg/dl)				0.136
Hyper (> 150)	13 (16.2)	4 (5.0)	7 (10.8)
Dyslipidemia				0.52
Yes	74 (92.5)	77 (96.2)	60 (92.3)
No	6 (7.5)	3 (3.8)	5 (7.7)